ORIFARM
LIVE

Serial Number

79370271

Owner

Orifarm Generics A/S

Attorney

Meichelle R. MacGregor

Filing Date

Jan 27, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ORIFARM Trademark

Serial Number: 79370271 • Registration: 7885422

ORIFARM is a trademark filed by Orifarm Generics A/S on January 27, 2023. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Orifarm Generics A/S

Energivej 15, Lindved, Postboks 69

Entity Type: 84

Trademark Details

Filing Date

January 27, 2023

Registration Date

August 12, 2025

Published for Opposition

March 11, 2025

Goods & Services

Surgical apparatus and instruments; medical and veterinary apparatus and instruments for surgical use; medical and veterinary apparatus and instruments for therapeutic use, namely, therapeutic equipment and devices for treating respiratory, metabolic and cardiovascular diseases in the nature of colds, coughing, nasal congestion, sore throat, ear congestion, sinus congestion, sinus inflammation, and inflammatory eye diseases; artificial limbs and eyes; orthopedic articles, namely, cushions, supports, padding, bandages, braces, footwear, hosiery, soles, belts, and walkers; suture materials; therapeutic articles and aids adapted for persons with disabilities, namely, compression wraps; massage apparatus; devices and articles for nursing infants, namely, bottles; devices and articles for sexual activity, namely, sex toys; the foregoing excluding dental equipment and other oral health care products

Non-medicated cosmetics and toiletry preparations, perfumery; essential oils; the foregoing excluding dental and other oral health care products

Pharmaceutical preparations and chemical preparations for medical and veterinary purposes, namely, for the treatment of metabolic and digestive conditions, hematopoietic and circulatory conditions, cardiac health conditions, dermatological conditions, urogenital conditions, sex hormonal conditions, systemic hormonal conditions, infectious diseases, antineoplastic and immunomodulatory conditions, musculoskeletal health conditions, neurological conditions, parasitological conditions, respiratory conditions, ocular and auditory health conditions, allergens-related conditions, hyperkalemia, hyperphosphatemia, calcium metabolic imbalances, and in the nature of pharmaceutical and medical preparations containing vitamins, minerals, antidotes, iron chelating agents, and contrast agents for the treatment of the aforementioned conditions; the foregoing excluding dental and other oral health care products

Retail and wholesale store services featuring non-medicated cosmetics and toiletries, perfumery, essential oils, pharmaceutical, medical and veterinary preparations, sanitary preparations for medical purposes, dietetic foods and preparations adapted for medical or veterinary use, foodstuffs for infants, dietary supplements for humans and animals, vitamins and vitamin preparations, medical plasters, medical dressings, surgical, medical, and veterinary apparatus and instruments, artificial limbs and eyes, orthopedic articles, suture materials, therapeutic articles and aids adapted for persons with disabilities, massage apparatus, devices and articles for nursing infants, devices and articles for sexual activity; the foregoing excluding dental equipment and other health care products

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 5, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 18, 2026 FICS
FINAL DISPOSITION PROCESSED
Feb 17, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 12, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 12, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 12, 2025 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jul 20, 2025 ETOP
POST PUBLICATION AMENDMENT - ENTERED
Jul 8, 2025 CHPB
ASSIGNED TO PETITION STAFF
Jul 7, 2025 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
May 12, 2025 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Apr 8, 2025 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 5, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 14, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 13, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 13, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 13, 2025 TROA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 9, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 23, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 23, 2024 OPNR
REFUSAL PROCESSED BY IB
Sep 21, 2024 RFNP
NON-FINAL ACTION WRITTEN
Aug 14, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 30, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 30, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 30, 2024 TROA
REFUSAL PROCESSED BY IB
Feb 27, 2024 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 31, 2024 RFCS
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 19, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 19, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 19, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 18, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 18, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 18, 2024 TROA
REFUSAL PROCESSED BY IB
Nov 22, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 30, 2023 RFCS
REFUSAL PROCESSED BY MPU
Oct 30, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 27, 2023 RFCR
NON-FINAL ACTION WRITTEN
Oct 26, 2023 CNRT
ASSIGNED TO EXAMINER
Oct 26, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
May 30, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 26, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 25, 2023 REPR